These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 36738224)
1. Zhang T; Zhang Y; Xu H; Lan J; Feng Z; Huang R; Geng J; Chi H; Bai X Antioxid Redox Signal; 2023 Aug; 39(4-6):225-240. PubMed ID: 36738224 [No Abstract] [Full Text] [Related]
2. Long Noncoding RNA LINC01619 Regulates MicroRNA-27a/Forkhead Box Protein O1 and Endoplasmic Reticulum Stress-Mediated Podocyte Injury in Diabetic Nephropathy. Bai X; Geng J; Li X; Wan J; Liu J; Zhou Z; Liu X Antioxid Redox Signal; 2018 Aug; 29(4):355-376. PubMed ID: 29334763 [TBL] [Abstract][Full Text] [Related]
3. WT1 ameliorates podocyte injury via repression of EZH2/β-catenin pathway in diabetic nephropathy. Wan J; Hou X; Zhou Z; Geng J; Tian J; Bai X; Nie J Free Radic Biol Med; 2017 Jul; 108():280-299. PubMed ID: 28315733 [TBL] [Abstract][Full Text] [Related]
4. ER Stress-Perturbed Intracellular Protein O-GlcNAcylation Aggravates Podocyte Injury in Diabetes Nephropathy. Song S; Hu T; Shi X; Jin Y; Liu S; Li X; Zou W; Wang C Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139429 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-27a promotes podocyte injury via PPARγ-mediated β-catenin activation in diabetic nephropathy. Zhou Z; Wan J; Hou X; Geng J; Li X; Bai X Cell Death Dis; 2017 Mar; 8(3):e2658. PubMed ID: 28277542 [TBL] [Abstract][Full Text] [Related]
6. LncRNA MALAT1 is dysregulated in diabetic nephropathy and involved in high glucose-induced podocyte injury via its interplay with β-catenin. Hu M; Wang R; Li X; Fan M; Lin J; Zhen J; Chen L; Lv Z J Cell Mol Med; 2017 Nov; 21(11):2732-2747. PubMed ID: 28444861 [TBL] [Abstract][Full Text] [Related]
7. Epigenetics and endoplasmic reticulum in podocytopathy during diabetic nephropathy progression. Wang X; Zhao J; Li Y; Rao J; Xu G Front Immunol; 2022; 13():1090989. PubMed ID: 36618403 [TBL] [Abstract][Full Text] [Related]
9. Rtn1a-Mediated Endoplasmic Reticulum Stress in Podocyte Injury and Diabetic Nephropathy. Fan Y; Zhang J; Xiao W; Lee K; Li Z; Wen J; He L; Gui D; Xue R; Jian G; Sheng X; He JC; Wang N Sci Rep; 2017 Mar; 7(1):323. PubMed ID: 28336924 [TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA SNHG5 promotes podocyte injury via the microRNA-26a-5p/TRPC6 pathway in diabetic nephropathy. Zhou Y; Li ZL; Ding L; Zhang XJ; Liu NC; Liu SS; Wang YF; Ma RX J Biol Chem; 2022 Dec; 298(12):102605. PubMed ID: 36257404 [TBL] [Abstract][Full Text] [Related]
11. Celastrol attenuates diabetic nephropathy by upregulating SIRT1-mediated inhibition of EZH2related wnt/β-catenin signaling. Tang Y; Wan F; Tang X; Lin Y; Zhang H; Cao J; Yang R Int Immunopharmacol; 2023 Sep; 122():110584. PubMed ID: 37454630 [TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA MEG3 suppresses podocyte injury in diabetic nephropathy by inactivating Wnt/β-catenin signaling. Che X; Deng X; Xie K; Wang Q; Yan J; Shao X; Ni Z; Ying L PeerJ; 2019; 7():e8016. PubMed ID: 31799068 [TBL] [Abstract][Full Text] [Related]
13. Down-regulation of PERK-ATF4-CHOP pathway by Astragaloside IV is associated with the inhibition of endoplasmic reticulum stress-induced podocyte apoptosis in diabetic rats. Chen Y; Gui D; Chen J; He D; Luo Y; Wang N Cell Physiol Biochem; 2014; 33(6):1975-87. PubMed ID: 25012492 [TBL] [Abstract][Full Text] [Related]
14. Protection of CTGF Antibody Against Diabetic Nephropathy in Mice Via Reducing Glomerular β-Catenin Expression and Podocyte Epithelial-Mesenchymal Transition. Dai HY; Ma LN; Cao Y; Chen XL; Shi H; Fan YP; Yang B J Cell Biochem; 2017 Nov; 118(11):3706-3712. PubMed ID: 28370212 [TBL] [Abstract][Full Text] [Related]
15. Emodin mitigates podocytes apoptosis induced by endoplasmic reticulum stress through the inhibition of the PERK pathway in diabetic nephropathy. Tian N; Gao Y; Wang X; Wu X; Zou D; Zhu Z; Han Z; Wang T; Shi Y Drug Des Devel Ther; 2018; 12():2195-2211. PubMed ID: 30034224 [TBL] [Abstract][Full Text] [Related]
16. RhoA protects the podocytes against high glucose-induced apoptosis through YAP and plays critical role in diabetic nephropathy. Huang Z; Peng Y; Yu H; Yu X; Zhou J; Xiao J Biochem Biophys Res Commun; 2018 Oct; 504(4):949-956. PubMed ID: 30220545 [TBL] [Abstract][Full Text] [Related]
17. Podocytes exhibit a specialized protein quality control employing derlin-2 in kidney disease. Ren G; Tardi NJ; Matsuda F; Koh KH; Ruiz P; Wei C; Altintas MM; Ploegh H; Reiser J Am J Physiol Renal Physiol; 2018 Mar; 314(3):F471-F482. PubMed ID: 29167172 [TBL] [Abstract][Full Text] [Related]
18. Silencing of long noncoding RNA PVT1 inhibits podocyte damage and apoptosis in diabetic nephropathy by upregulating FOXA1. Liu DW; Zhang JH; Liu FX; Wang XT; Pan SK; Jiang DK; Zhao ZH; Liu ZS Exp Mol Med; 2019 Aug; 51(8):1-15. PubMed ID: 31371698 [TBL] [Abstract][Full Text] [Related]
19. Apelin promotes diabetic nephropathy by inducing podocyte dysfunction via inhibiting proteasome activities. Guo C; Liu Y; Zhao W; Wei S; Zhang X; Wang W; Zeng X J Cell Mol Med; 2015 Sep; 19(9):2273-85. PubMed ID: 26103809 [TBL] [Abstract][Full Text] [Related]
20. FOXO3a accumulation and activation accelerate oxidative stress-induced podocyte injury. Chen X; Liu W; Xiao J; Zhang Y; Chen Y; Luo C; Huang Q; Peng F; Gong W; Li S; He X; Zhuang Y; Wu N; Liu Y; Wang Y; Long H FASEB J; 2020 Oct; 34(10):13300-13316. PubMed ID: 32786113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]